Showing results (551-560 of 641) with videos related to
Sort By:
Pageof 65
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 3, 2014
Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantationTomokazu Kawaoka, Shoichi Takahashi, Yumiko Tatsukawa, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 15, 2025
Usefulness of preoperative peripheral blood GPC3-positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort studyYosuke Namba, Tsuyoshi Kobayashi, Yoshito Hirata, et al.Journal of Radiation Research|December 20, 2020
Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancerNobuki Imano, Yuji Murakami, Katsumaro Kubo, et al.Plos One|February 5, 2021
Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, JapanKo Ko, Shintaro Nagashima, Bunthen E, et al.Oncology|October 9, 2023
Kinesin Family Member B18 Is Related to Gastric Mucin Phenotype and Contributes to Gastric Cancer Progression by Regulating Epithelial-Mesenchymal TransitionAkira Ishikawa, Ryo Yasumatsu, Takafumi Fukui, et al.Journal of Gastroenterology and Hepatology|March 22, 2012
Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantationTomokazu Kawaoka, Shoichi Takahashi, Shintaro Takaki, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|October 27, 2004
Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantationHirotaka Tashiro, Toshiyuki Itamoto, Hideki Ohdan, et al.Plos One|August 26, 2016
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab TreatmentRyuichi Hotta, Masahiro Ohira, Toshiharu Matsuura, et al.Nutrition (Burbank, Los Angeles County, Calif.)|May 11, 2018
Effect of herbal medicine daikenchuto on oral and enteral caloric intake after liver transplantation: A multicenter, randomized controlled trialToshimi Kaido, Masahiro Shinoda, Yukihiro Inomata, et al.Critical Care Explorations|November 12, 2021
Identification of Aggravation-Predicting Gene Polymorphisms in Coronavirus Disease 2019 Patients Using a Candidate Gene Approach Associated With Multiple Phase Pathogenesis: A Study in a Japanese City of 1 Million PeopleNaoki Tanimine, Daisuke Takei, Naohumi Tsukiyama, et al.Pageof 65